Literature DB >> 11312336

Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.

J L Jiménez1, J González-Nicolás, S Alvarez, M Fresno, M A Muñoz-Fernández.   

Abstract

Addition of nitric oxide (NO) donors to mitogen-activated human immunodeficiency virus type 1 (HIV-1)-infected peripheral blood mononuclear cultures produced a significant increase in virus replication, and this effect was not associated with a change in cell proliferation. This effect was only observed with T-tropic X4 or X4R5 virus but not with R5 virus. Moreover, HIV-1 replication in mitogen-stimulated cultures was partially prevented by the specific inhibitors of the inducible nitric oxide synthase (iNOS). NO donors also enhanced HIV-1 infection of the human T-cell lines, Jurkat and MT-2. We have also observed that NO leads to an enhancement of HIV-1 replication in resting human T cells transfected with a plasmid carrying the entire HIV-1 genome and activated with phorbol ester plus ionomycin. Thus, in those cultures NO donors strongly potentiated HIV-1 replication in a dose-dependent manner, up to levels comparable to those with tumor necrosis factor alpha (TNF-alpha) stimulation. Furthermore, iNOS inhibitors decreased HIV-1 replication in HIV-1-transfected T cells to levels similar to those obtained with neutralizing anti-TNF-alpha antibodies. Moreover, HIV-1 replication induced iNOS and TNF-alpha transcription in T cells and T-cell lines. Interestingly, NO donors also stimulated long terminal repeat (LTR)-driven transcription whereas iNOS inhibitors partially blocked TNF-alpha-induced LTR transcription. Therefore, our results suggest that NO is involved in HIV-1 replication, especially that induced by TNF-alpha.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312336      PMCID: PMC114219          DOI: 10.1128/JVI.75.10.4655-4663.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  HIV-1 infection induces differentiation of immature neural cells through autocrine tumor necrosis factor and nitric oxide production.

Authors:  E Obregón; C Punzón; E Fernández-Cruz; M Fresno; M A Muñoz-Fernández
Journal:  Virology       Date:  1999-09-01       Impact factor: 3.616

Review 2.  Nitric oxide as a signaling molecule in the vascular system: an overview.

Authors:  L J Ignarro; G Cirino; A Casini; C Napoli
Journal:  J Cardiovasc Pharmacol       Date:  1999-12       Impact factor: 3.105

Review 3.  Role of nitric oxide in autoimmunity.

Authors:  A O Vladutiu
Journal:  Clin Immunol Immunopathol       Date:  1995-07

4.  Nitric oxide upregulates expression of DNA-PKcs to protect cells from DNA-damaging anti-tumour agents.

Authors:  W Xu; L Liu; G C Smith; l G Charles
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

5.  Nitric oxide inhibits HIV tat-induced NF-kappaB activation.

Authors:  F Chen; Y Lu; V Castranova; Y Rojanasakul; K Miyahara; Y Shizuta; V Vallyathan; X Shi; L M Demers
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

6.  Nitric oxide modulates HIV-1 replication.

Authors:  J B Mannick; J S Stamler; E Teng; N Simpson; J Lawrence; J Jordan; R W Finberg
Journal:  J Acquir Immune Defic Syndr       Date:  1999-09-01       Impact factor: 3.731

Review 7.  The antiviral effects of nitric oxide.

Authors:  K L Powell; S A Baylis
Journal:  Trends Microbiol       Date:  1995-03       Impact factor: 17.079

8.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 9.  Nitric oxide: what role does it play in inflammation and tissue destruction?

Authors:  C H Evans
Journal:  Agents Actions Suppl       Date:  1995

10.  Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

Authors:  H B Peng; P Libby; J K Liao
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  10 in total

Review 1.  Current views on HIV-1 latency, persistence, and cure.

Authors:  Zora Melkova; Prakash Shankaran; Michaela Madlenakova; Josef Bodor
Journal:  Folia Microbiol (Praha)       Date:  2016-10-05       Impact factor: 2.099

Review 2.  Role of nitric oxide in immune responses against viruses: beyond microbicidal activity.

Authors:  Elaine Uchima Uehara; Beatriz de Stefano Shida; Cyro Alves de Brito
Journal:  Inflamm Res       Date:  2015-07-25       Impact factor: 4.575

3.  Chemoprevention of Colon Cancer by iNOS-Selective Inhibitors.

Authors:  Naveena B Janakiram; Chinthalapally V Rao
Journal:  For Immunopathol Dis Therap       Date:  2012-01-01

4.  LMP-420, a small-molecule inhibitor of TNF-alpha, reduces replication of HIV-1 and Mycobacterium tuberculosis in human cells.

Authors:  Soichi Haraguchi; Noorbibi K Day; Wasu Kamchaisatian; Macarena Beigier-Pompadre; Steffen Stenger; Nutthapong Tangsinmankong; John W Sleasman; Salvatore V Pizzo; George J Cianciolo
Journal:  AIDS Res Ther       Date:  2006-03-31       Impact factor: 2.250

5.  Nutritional supplementation with the mushroom Agaricus sylvaticus reduces oxidative stress in children with HIV.

Authors:  Marcela S Figueira; Luana A Sá; Amanda S Vasconcelos; Danilo R Moreira; Paula Soc Laurindo; Danielle Rg Ribeiro; Rogério S Santos; Paulo Guzzo; Maria F Dolabela; Sandro Percario
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-09       Impact factor: 2.471

Review 6.  Oxidative Stress during HIV Infection: Mechanisms and Consequences.

Authors:  Alexander V Ivanov; Vladimir T Valuev-Elliston; Olga N Ivanova; Sergey N Kochetkov; Elizaveta S Starodubova; Birke Bartosch; Maria G Isaguliants
Journal:  Oxid Med Cell Longev       Date:  2016-10-13       Impact factor: 6.543

7.  Characterization of the placental macrophage secretome: implications for antiviral activity.

Authors:  K García; V García; J Pérez Laspiur; F Duan; L M Meléndez
Journal:  Placenta       Date:  2008-12-12       Impact factor: 3.481

8.  Akt inhibitors as an HIV-1 infected macrophage-specific anti-viral therapy.

Authors:  Pauline Chugh; Birgit Bradel-Tretheway; Carlos M R Monteiro-Filho; Vicente Planelles; Sanjay B Maggirwar; Stephen Dewhurst; Baek Kim
Journal:  Retrovirology       Date:  2008-01-31       Impact factor: 4.602

9.  Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

Authors:  Ajay Wanchu; Archana Bhatnagar; Madhu Khullar; Archana Sud; Pradeep Bambery; Surjit Singh
Journal:  BMC Infect Dis       Date:  2002-07-29       Impact factor: 3.090

Review 10.  Nitric oxide in dengue and dengue haemorrhagic fever: necessity or nuisance?

Authors:  Umesh C Chaturvedi; Rachna Nagar
Journal:  FEMS Immunol Med Microbiol       Date:  2009-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.